Competere contribution to the European Commission’s Pharmaceuticals Strategy Roadmap
Dopo aver partecipato alla consultazione della Commissione Europea sulla strategia farmaceutica, Competere partecipa all’azione congiunta portata avanti insieme al Geneva Network, all’Information Technology and Innovation Foundation (ITIF), all’Istituto per la Competitività (I-Com) e alla Foundation for Economic & Industrial Research chiedendo al Commissario per la Salute e la Sicurezza Alimentare, Stella Kyriakides, di agire su […]
Competere participated in European Commission consultation on new EU strategy for Pharmaceuticals
Here an excerpt of Competere’s feedback to European Commission consultation on the new plan for Pharmaceuticals. Innovation is fundamental for economic growth. Therefore, European Commission should avoid implementing policies that threaten or constraint it. As a think tank focused on innovation policies, our aim is to help the European institution to pursue the specific objectives […]
It’s Time the WHO and the Private Sector Acted Together to Tackle Barriers to Healthcare
At the World Health Organization’s (WHO) Executive Board meeting in Geneva, member states will establish the global health agenda for 2020. One of the priority agenda items is finding sustainable pathways to implement universal health coverage (UHC) – a United Nations-backed initiative to ensure affordable access to basic health services. The issue has remained a […]
Non Affondiamo l’Industria Farmaceutica
L’industria farmaceutica spinge la crescita, investe, innova, eppure continua ad essere penalizzato dalla regolamentazione e dall’incertezza amministrativa. Il perverso meccanismo del Payback minaccia gli investimenti e la capacità delle aziende di produrre innovazione. Nel frattempo politica e burocrazia non garantiscono stabilità e certezza delle regole. Non sarà certo la legge di Bilancio in discussione a […]
License to Kill
WHY IT IS IMPORTANT WHO threatens patents and intellectual property, risking to discourage innovation. Compulsory licenses allow the State to override intellectual property rights to manufacture patented medicines without the patent-owner’s consent at a more competitive cost, making them available to a larger number of citizens. GOOD-HEARTED The concern with improving access to medicines is […]
International Think Tanks Dialogue on Health, Trade and Innovation – 25 settembre, Bogota
Il Presidente di Competere, Pietro Paganini, tra gli speaker della tavola rotonda internazionale International Think Tanks Dialogue on Health Trade and Innovation che si è tenuta a Bogota, Colombia, il 25 settembre 2018. Il tema dell’evento: politiche per l’innovazione e il libero commercio innovazione e sanità rapporti multilaterali fra i paesi OCSE Pietro Paganini è […]
The real prescription for lower drug prices: get Europe to drop its price controls
It’s no secret that transatlantic relations have been a bit stormy recently, due in part to President Trump disparaging European countries as “freeloaders” who invest comparatively less in research and development for new medicines while suppressing drug prices through government controls. Nor is it surprising that Europeans have taken exception to his belligerent tone. But […]